A randomised double‐blind placebo‐controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease

Abstract

This pilot double blind study suggests that response to ChI in patients with AD may be improved by the use of folic acid. The relationship between any change in homocysteine levels and response to treatment is discussed.